Journal of Psychiatry

Abstract

The efficacy of Boswellic acids on cognition after traumatic brain injury: A double-blind, randomized, placebo-controlled clinical trial - Shakila Meshkat - Tehran University of Medical Sciences

Shakila Meshkat

Traumatic brain injury (TBI) is one of the most frequent causes of brain damage. In adults, TBI frequently results in impairments of cognitive functions which can lead to psychological consequences in the future. Boswellia acid (BA) is an anti-inflammatory agent with neuroprotective activity, which could markedly improve cognitive function. In this study, we aimed to evaluate the effect of BAs, a traditional herbal medicine, on cognitive function of patients with TBI.

Published Date: 2021-06-28;